JP2011502147A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502147A5
JP2011502147A5 JP2010532037A JP2010532037A JP2011502147A5 JP 2011502147 A5 JP2011502147 A5 JP 2011502147A5 JP 2010532037 A JP2010532037 A JP 2010532037A JP 2010532037 A JP2010532037 A JP 2010532037A JP 2011502147 A5 JP2011502147 A5 JP 2011502147A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutical composition
base
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010532037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502147A (ja
JP5343082B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012224 external-priority patent/WO2009058267A2/en
Publication of JP2011502147A publication Critical patent/JP2011502147A/ja
Publication of JP2011502147A5 publication Critical patent/JP2011502147A5/ja
Application granted granted Critical
Publication of JP5343082B2 publication Critical patent/JP5343082B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010532037A 2007-10-29 2008-10-28 ベンゾモルホリン誘導体および使用方法 Expired - Fee Related JP5343082B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94807P 2007-10-29 2007-10-29
US61/000,948 2007-10-29
PCT/US2008/012224 WO2009058267A2 (en) 2007-10-29 2008-10-28 Benzomorpholine derivatives and methods of use

Publications (3)

Publication Number Publication Date
JP2011502147A JP2011502147A (ja) 2011-01-20
JP2011502147A5 true JP2011502147A5 (enExample) 2011-09-22
JP5343082B2 JP5343082B2 (ja) 2013-11-13

Family

ID=40394086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532037A Expired - Fee Related JP5343082B2 (ja) 2007-10-29 2008-10-28 ベンゾモルホリン誘導体および使用方法

Country Status (8)

Country Link
US (1) US7795254B2 (enExample)
EP (1) EP2220078B1 (enExample)
JP (1) JP5343082B2 (enExample)
AU (1) AU2008319366B2 (enExample)
CA (1) CA2703257C (enExample)
ES (1) ES2417009T3 (enExample)
MX (1) MX2010004620A (enExample)
WO (1) WO2009058267A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684182A5 (de) 1991-10-15 1994-07-29 Escher Wyss Ag Rotationsdruckmaschine.
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
RU2580318C2 (ru) * 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
US9199919B2 (en) 2010-05-19 2015-12-01 Sandoz Ag Process for the preparation of chiral hydrazides
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755332A (en) 1971-07-01 1973-08-28 Ciba Geigy Corp Substituted 4 indazolaminoquinolines
US4916135A (en) 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
WO1996023774A1 (en) 1995-01-31 1996-08-08 Zenyaku Kogyo Kabushiki Kaisha Thioquinoline derivatives
GB9505702D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd Fungicidal compounds
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
WO1997017329A1 (en) 1995-11-07 1997-05-15 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
JPH10512896A (ja) 1995-11-14 1998-12-08 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー アリールおよびヘテロアリールプリン化合物
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE19614718A1 (de) 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
ATE293102T1 (de) 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung
EP1105378B1 (en) 1998-08-21 2005-03-30 Parker Hughes Institute Quinazoline derivatives
BRPI0017548B8 (pt) 1999-02-10 2023-05-02 Astrazeneca Ab Composto
US6258820B1 (en) 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
EE200100528A (et) 1999-04-12 2003-02-17 Aventis Pharma Limited Asendatud bitsükliline heteroarüülühend, seda sisaldav farmatseutiline kompositsioon ning nende raviotstarbeline kasutamine
AU2001292138A1 (en) 2000-10-13 2002-04-22 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
EP1415987B1 (en) 2000-10-20 2007-02-28 Eisai R&D Management Co., Ltd. Nitrogenous aromatic ring compounds as anti cancer agents
CA2454538A1 (en) 2001-06-22 2003-01-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
JP2005515176A (ja) 2001-11-03 2005-05-26 アストラゼネカ アクチボラグ 抗腫瘍剤としてのキナゾリン誘導体
GB0126433D0 (en) 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
CN1625555A (zh) 2002-02-01 2005-06-08 阿斯特拉曾尼卡有限公司 喹唑啉化合物
US7645878B2 (en) 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
ATE447404T1 (de) 2002-03-29 2009-11-15 Novartis Vaccines & Diagnostic Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
CN1688549A (zh) 2002-08-23 2005-10-26 麒麟麦酒株式会社 具有TGFβ抑制活性的化合物和含所述化合物的药用组合物
US7320989B2 (en) 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
WO2004078114A2 (en) 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
US7531553B2 (en) 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
GB0310401D0 (en) 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent
US7312330B2 (en) 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
JP4932495B2 (ja) * 2004-01-23 2012-05-16 アムゲン インコーポレイテッド 化合物及び使用方法
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use

Similar Documents

Publication Publication Date Title
JP2006524222A5 (enExample)
JP2016512822A5 (enExample)
JP2008255122A5 (enExample)
JP2009143956A5 (enExample)
JP2012510502A5 (enExample)
JP2011529054A5 (enExample)
JP2009536660A5 (enExample)
JP2015537020A5 (enExample)
JP2005526011A5 (enExample)
JP2008533007A5 (enExample)
JP2010527983A5 (enExample)
JP2008518890A5 (enExample)
JP2008505157A5 (enExample)
JP2015501820A5 (enExample)
JP2014506907A5 (enExample)
JP2012513416A5 (enExample)
JP2015508092A5 (enExample)
JP2010520214A5 (enExample)
JP2014505017A5 (enExample)
JP2018529690A5 (enExample)
JP2023552610A5 (enExample)
JP2012509265A5 (enExample)
JP2018529657A5 (enExample)
JP2010534246A5 (enExample)
JP2009040767A5 (enExample)